beneficios del tirzepatide Cómo actúa tirzepatida, la nueva molécula dual e inyectable para el tratamiento de la obesidad y la diabetes disponible en Argentina Tirzepatida (Mounjaro®), el agonista dual

While this offers a promising treatment avenue, the effects in other clinical models remain limited, and long-term treatment toxicity requires further study

*Correspondence: Lishou Xiong, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

The key advantages of therapeutic peptides include their high potency, selectivity, minimum side effects, specificity for their target receptors, minimal drug-drug interactions, and reduced immunogenicity [1]

Investigational drug status affects how Retatrutide can be obtained and used in different jurisdictions